MedPath

Role of oral melatonin in prevention of catheter related bladder discomfort (CRBD) in patients undergoing surgery for benign prostate hypertrophy

Phase 3
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2024/01/062153
Lead Sponsor
Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. American Society of Anaesthesiologists - Physical Status grade 1 and 2, 2. Patients undergoing elective TURP under Subarachnoid block and 3. Patients who undergoing urinary catheterisation.

Exclusion Criteria

1. Patents with liver and renal failure. 2. Refusal or contraindication for spinal anaesthesia. 3. Patients on chronic analgesics. 4. Psychiatric Disorders and inability to communicate. 5. Overactive bladder, neurogenic bladder, bladder outflow obstruction. 6. Patients with autoimmune diseases such as rheumatoid arthritis and post organ transplant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence and severity of CRBDTimepoint: 0,2,8,12 and 24 hour
Secondary Outcome Measures
NameTimeMethod
Patient satisfaction scoreTimepoint: At 6th hour;SedationTimepoint: On table and 24 hours;Visual analogue scaleTimepoint: 0,2,8,12 and 24 hour
© Copyright 2025. All Rights Reserved by MedPath